Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1845-1848, 2004. First published August 12, 2004; 10.1373/clinchem.2004.037416
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.037416v1
50/10/1845    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Annesley, T. M.
Right arrow Articles by Clayton, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Annesley, T. M.
Right arrow Articles by Clayton, L.
Related Collections
Right arrow Drug Monitoring and Toxicology
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:1845-1848.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Simple Extraction Protocol for Analysis of Immunosuppressant Drugs in Whole Blood

Thomas M. Annesleya and Larry Clayton

1 University of Michigan Health Systems, 1500 East Medical Center Dr., Ann Arbor, MI 48109-0054;

aauthor for correspondence: e-mail annesley@umich.edu

The first 20% of the full text of this article appears below.

The immunosuppressant drugs cyclosporine (cyclosporin A), tacrolimus, sirolimus, and everolimus are used to prevent organ rejection. Because commercial immunoassays are available only for cyclosporine and tacrolimus, HPLC (1)(2)(3), often in conjunction with mass spectrometry (MS or MS/MS) (4)(5)(6)(7), has been used to quantify these drugs.

For MS/MS, sample preparation has often involved simple protein precipitation and solvent dissolution. Protocols have used zinc sulfate followed by acetonitrile (8), methanol (9), or acetone (10). Sometimes these reagents are premixed (11)(12)(13)(14). During in-house assay development we encountered several problems when zinc sulfate and acetonitrile were used. For example, many specimens clumped when blood was added to the zinc sulfate. Even after addition of acetonitrile and vortex-mixing, the clumps remained, necessitating manual dislodgement of the pellet. This occurred with lysed human blood specimens, lyophilized whole-blood controls (e.g., Bio-Rad Lyphochek), and College of American Pathologists proficiency testing specimens. We substituted methanol for acetonitrile with minor improvement. Another problem was that the recovery of sirolimus from whole blood using zinc sulfate followed by acetonitrile or methanol was <100% (9). In addition, the observed MS/MS responses for commercial calibrators and controls were often ~30% higher than for human blood specimens.

Here we present a new extraction protocol that improves absolute recoveries, provides excellent precision, and shows less ion suppression. Although the performance of this protocol for several immunosuppressants is described, we present example data only for sirolimus. We also describe a solid-phase extraction (SPE) that may be added to further enhance the cleanliness of extracts.

For recovery and extraction experiments, we used cyclosporine from . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
T. M. Annesley
Methanol-Associated Matrix Effects in Electrospray Ionization Tandem Mass Spectrometry
Clin. Chem., October 1, 2007; 53(10): 1827 - 1834.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. L. Napoli
Organic solvents compromise performance of internal standard (ascomycin) in proficiency testing of mass spectrometry-based assays for tacrolimus.
Clin. Chem., April 1, 2006; 52(4): 765 - 766.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
P. J. Taylor, S. R. Brown, D. P. Cooper, P. Salm, M. R. Morris, P. I. Pillans, and S. V. Lynch
Evaluation of 3 Internal Standards for the Measurement of Cyclosporin by HPLC-Mass Spectrometry
Clin. Chem., October 1, 2005; 51(10): 1890 - 1893.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
G. Khoschsorur
Simultaneous Measurement of Sirolimus and Everolimus in Whole Blood by HPLC with Ultraviolet Detection
Clin. Chem., September 1, 2005; 51(9): 1721 - 1724.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
T. M. Annesley and L. T. Clayton
Quantification of Mycophenolic Acid and Glucuronide Metabolite in Human Serum by HPLC-Tandem Mass Spectrometry
Clin. Chem., May 1, 2005; 51(5): 872 - 877.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. M. Annesley
Application of Commercial Calibrators for the Analysis of Immunosuppressant Drugs in Whole Blood
Clin. Chem., February 1, 2005; 51(2): 457 - 460.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.